Clearmind Signs Definitive Deal for 51% of EV Wireless Charging Firm
CMND sits 29% above its 52-week low of $1.43 on light trading volume (0.1× avg).
Summary
Clearmind Medicine has signed a definitive agreement to acquire a 51% stake in a wireless charging company focused on automated parking and robotaxis. This follows a non-binding letter of intent disclosed on August 3, 2026, and represents a firm commitment to enter the EV infrastructure space. The move diversifies Clearmind beyond its core CNS drug development, where it has been burning cash and relying on dilutive financings. The acquisition could provide a new revenue stream, but terms and financing are not yet disclosed. Investors should watch for the closing conditions and any capital raise needed to fund the purchase.
At the time of this announcement, CMND was trading at $1.85 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $1.43 to $524.00. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.